Google has selected 20 AI-powered Indian startups for the 2026 cohort of its Google Play Accelerator India programme. The selected startups are building across education, healthcare, gaming, agriculture, finance, ecommerce, productivity, lifestyle and entertainment.

The programme is three months long and equity-free, which means Google does not take ownership in the startups for participation. Instead, the selected companies get hands-on support from Google teams in areas such as AI integration, app quality, security, growth, monetization and global expansion.

This selection matters because Indian app startups are no longer building only for local users. Many are now using AI to solve everyday problems and also thinking about global markets from day one.

What is Google Play Accelerator India

Google Play Accelerator India is a startup support programme focused on app and game companies.

It is designed for Indian startups that already have a product, users and growth potential. The programme helps them improve their apps, use AI better, protect user data, grow faster and earn revenue through stronger monetization strategies.

For example, a learning app may need help improving AI-based practice sessions. A gaming startup may need support with user retention and in-app purchases. A health app may need better privacy and security systems. Google’s teams can guide founders on such problems through product reviews, technical sessions and growth support.

The 2026 cohort shows how deeply AI has entered India’s app ecosystem.

The 20 startups selected

The selected startups include Chaupal, ChennaiGames, Dalvoy, Frontier Markets, GAPE Labs, Grape, HeyDoc AI, Kisanwala, Lingopanda, LUZO, Machaxi, MetaShot, MindYourLogic Studios, MrMed, Plutus Labs Inc., Regain, Swipe, UrbanPro, Zave AI and Zet.

These startups cover a wide range of sectors.

Chaupal works in regional entertainment. ChennaiGames, GAPE Labs, MetaShot, MindYourLogic Studios and Plutus Labs are in gaming and interactive media. Dalvoy, Lingopanda and UrbanPro are focused on education. HeyDoc AI, Machaxi and MrMed are working in health. Kisanwala serves the agriculture market. Swipe, Zave AI, Zet and Frontier Markets work across finance, ecommerce and small business use cases.

This mix is interesting because it shows AI is not limited to one category. It is now entering farms, classrooms, clinics, games, shopping apps and small business tools.

Why Google selected these startups

Google’s aim is to support high-potential Indian app and game startups at a stage where practical guidance can make a big difference.

Many founders can build a good first version of an app. The harder part comes later. They need to improve speed, reduce bugs, use AI safely, protect user data, keep customers engaged and build a revenue model that actually works.

That is where an accelerator helps.

For instance, an app may have many downloads but poor retention. Another may use AI but give inconsistent results. A gaming startup may have a fun product but weak monetization. A health startup may need stronger security before scaling. Google Play Accelerator can help founders fix such gaps before they become bigger problems.

What kind of support startups get

The selected startups will receive support across AI, product quality, security, growth and monetization.

AI support is important because many startups are adding AI features quickly, but not all AI features are useful or reliable. Google can help founders improve how AI works inside their apps, whether it is for personalization, recommendations, chat, voice, content creation or automation.

App quality support can help with crashes, speed, design and user experience. Security support matters because apps now handle personal data, health information, payments and user behaviour.

Growth and monetization support can help startups understand how to acquire users, keep them active and earn revenue without hurting the user experience.

Why this matters for Indian users

For Indian users, this programme can lead to better apps.

A student preparing for government exams may get more personalized revision through an AI learning app. A farmer may access better input buying and machinery rental through an agritech platform. A family may use AI health tools to manage care better. A small business owner may invoice customers through WhatsApp and receive payments faster.

These are not luxury problems. They are everyday use cases.

If these startups improve through the accelerator, users may get apps that are faster, safer, more useful and easier to trust.

Why this matters for Indian startups

For startups, Google’s selection gives credibility.

Being part of the programme can help a young company attract customers, partners, investors and talent. It also gives founders access to expert advice that may otherwise be difficult or expensive to get.

This is especially useful for startups outside the usual SaaS or fintech bubble. Gaming, education, agriculture, health and regional entertainment companies often need different growth playbooks. Google Play’s app ecosystem knowledge can help them understand what works in India and what can scale globally.

The equity-free nature of the programme is also important. Startups can get support without giving up shares.

The bigger AI trend

The cohort reflects a larger trend in India. AI is moving from buzzword to product feature.

A few years ago, many startups used AI mainly for marketing. Now, founders are using it to improve core products. AI can help learners practise English, assist doctors with patient workflows, help shoppers find the right product, reduce doomscrolling, create games faster, or support rural commerce.

Google’s broader startup programmes in India have also focused on AI-first companies. The company’s 2026 Google for Startups Accelerator India cohort was selected from around 2,500 applications and focused on AI startups in areas such as climate, healthcare, finance, cybersecurity and developer tools.

This shows that India’s AI ecosystem is becoming deeper, not just larger.

Competitors and similar programmes

Google is not the only major player supporting Indian startups.

Microsoft supports startups through Microsoft for Startups Founders Hub and AI-focused cloud programmes. AWS runs startup accelerators and has also supported space-tech and AI startups in India. Meta has worked with Indian startups and developers around digital tools and AI. MeitY Startup Hub, T-Hub, Nasscom, Startup India and several private accelerators also support early-stage companies.

But Google Play Accelerator has a clear advantage for mobile-first startups. Google Play is one of the most important distribution platforms for Android apps in India. That gives Google direct insight into app quality, user behaviour, store performance, safety and monetization.

For app-based startups, that guidance can be very practical.

Challenges ahead

Selection is only the beginning.

The real test will be whether these startups can turn accelerator support into stronger products and real business growth. AI features must be accurate, useful and safe. Apps must protect user data. Gaming startups must balance engagement with responsible monetization. Health and finance apps must build deep trust.

Startups also need to avoid adding AI only because it sounds modern. Users care about outcomes. Does the app save time? Does it solve a real problem? Is it easy to use? Is it worth paying for?

The startups that answer these questions well will benefit most from the programme.

Conclusion with key takeaways

Google selecting 20 AI-powered Indian startups for Play Accelerator India 2026 is a strong signal for the country’s app economy. Indian founders are building beyond simple utility apps and using AI in education, health, gaming, agriculture, finance, ecommerce and entertainment.

The programme’s purpose is to help these startups improve AI integration, app quality, security, growth and monetization. For founders, it can bring sharper product thinking. For users, it can mean better and safer apps. For India, it supports the larger goal of building globally relevant digital products from within the country.

Key takeaways –

1. Google has selected 20 AI-powered Indian startups for Play Accelerator India 2026.
2. The programme is three months long and equity-free.
3. Selected startups will get support in AI integration, app quality, security, growth and monetization.
4. The cohort includes startups across education, healthcare, gaming, agriculture, finance, ecommerce, productivity, lifestyle and entertainment.
5. The selection shows how AI is becoming central to India’s mobile app ecosystem.

Facts Input- Google

Indian startup funding between June 29 and July 24, 2026, had an interesting mix of large growth rounds, selective early-stage bets and strong action in AI, EVs, enterprise software, healthtech, spacetech and consumer brands.

The period did not move in a straight line. Some days were packed with deals, while others were quiet. But one thing was clear. Investors were not writing cheques randomly. They were backing companies with sharper use cases, better revenue visibility, strong founders or clear IPO plans.

This India startup funding update June 29 to July 24, 2026, brings together the key funding deals, investors and founders to watch from publicly reported updates during this window.

Funding mood during the period

1. The last days of June opened strongly. On June 29, Incuspaze raised Rs. 150 crore, Rusk Media raised Rs. 100 crore, Mykare closed seed funding at $3.2 million, and smaller rounds went to The Func. Lab, Lytmus AI, The Capitalist Ventures and Clairva.
2. June 30 continued with consumer and SaaS activity. The Indus Valley raised $17 million led by Gaja Capital, Kapture CX raised $10 million from Bajaj Finserv Ventures, and YoLearn.ai raised $500,000 in pre-seed funding.
3. July started with bigger consumer and manufacturing-linked deals. Limelight Diamonds raised Rs. 275 crore on July 1, while Celloraa Energy received Rs. 160 crore from StarlinePS Enterprises for a solar cell plant. Dovetail Capital, Supply6, Data Science Wizards and Spense also raised funding the same day.
4. After that, July became uneven. According to Inc42, Indian startups raised $71.9 million across 17 deals between July 4 and July 10, down from $104.6 million in the previous week. Then the third week bounced back sharply, with reports saying startups raised around $281.4 million across 24 deals between July 11 and July 17. The fourth week, July 18 to July 24, cooled again to around $209.1 million across 14 deals.

Biggest deals to know

1. Ather Energy was one of the biggest names in this period. The electric two-wheeler maker raised Rs. 1,300 crore through a QIP on July 21, after earlier funding activity around a preferential issue. This money is important because EV manufacturing needs heavy spending on factories, R&D, batteries, marketing and working capital.
2. BusinessNext raised $40 million in Series C from ServiceNow Ventures at a reported $700 million valuation. The company builds banking software and private AI tools for financial institutions. This was one of the strongest enterprise SaaS stories of the period.
3. Emergent became one of the biggest AI funding stories, raising $130 million in Series C at a $1.5 billion valuation. The company works on AI software creation, and its round showed that investors are still willing to fund serious AI companies when the product has strong demand.
4. Raghu Vamsi Aerospace Group raised $40 million in Series B, co-led by Norwest and Skegen Asset Management. This deal showed investor interest in aerospace manufacturing and defence-linked deeptech.
5. SolarSquare also stood out with its $53 million Series C round. The residential rooftop solar startup has become an important clean energy company to watch, especially as Indian households look for lower electricity bills and cleaner power.

Daily deal snapshot

• June 29 – Incuspaze, Rusk Media, Mykare, The Func. Lab, Lytmus AI, The Capitalist Ventures and Clairva raised funds.
• June 30 – The Indus Valley, Kapture CX and YoLearn.ai closed funding rounds.
• July 1 – Limelight Diamonds, Celloraa Energy, Dovetail Capital, Supply6, Data Science Wizards and Spense were among the major updates.
• July 2 – BatX Energies raised Rs. 105 crore, Age Care Labs raised Rs. 85 crore, and Tulon Materials raised Rs. 10 crore.
• July 3 – CUNIN raised $450,000 in a quiet funding day.
• July 6 – TOCAL raised Rs. 9 crore in seed funding.
• July 7 – Econovus Packaging raised Rs. 40 crore, Mowito raised $3 million, and Fizzy Goblet received investment from Kareena Kapoor Khan.
• July 8 – Elevate Education raised Rs. 170 crore from WestBridge Capital, while Milo Drive, Doodhvale Farms, Neothera and others also raised capital.
• July 9 – Wheelocity raised Rs. 82 crore, while BAAS Technologies raised Rs. 5 crore in pre-seed funding.
• July 10 – Purple Style Labs raised Rs. 162.5 crore debt, and Aukera raised Rs. 90 crore.
• July 13 – Dhruva Space raised Rs. 60 crore from Antariksh Venture Capital Fund.
• July 14 – BUILT raised $2 million in pre-seed funding.
• July 15 – Ather Energy, Emergent and E3 Electric.Ai were among the headline names.
• July 16 – Naturis Cosmetics raised Rs. 100 crore, Vorflux raised $15 million, and NapTapGo raised Rs. 8 crore.
• July 17 – Neo Group raised Rs. 350 crore led by Peak XV Partners.
• July 20 – Raghu Vamsi Aerospace raised $40 million, Plazza raised $15 million, and LNGVTY raised Rs. 5 crore.
• July 21 – Ather Energy, SolarSquare, 30 Sundays, Suminter India Organics, FireAI and Khageshvara Aviation Technology were in the funding news.
• July 22 – Bioscan Research raised $1 million in seed funding led by Unicorn India Ventures.
• July 23 – BusinessNext, CARPL.ai, Farm Watt Innovations, Wiffy, NeuralKart and UpKraft raised funds.
• July 24 – Sortmyprep funding round was reported in as daily update.

Founders to watch

• Sanjay Choudhary and Sanjay Chatrath of Incuspaze are worth watching as managed office demand keeps rising in India.
• Tarun Mehta and Swapnil Jain of Ather Energy remain key names in India’s EV story, especially as the company prepares for higher manufacturing needs.
• Shreya Mishra and Nikhil Nahar of SolarSquare are building in rooftop solar, a category that can grow as power costs and clean energy awareness rise.
• Vidur Mahajan of CARPL.ai is building in medical imaging AI, a space where hospitals need practical tools, not just fancy dashboards.
• Anupam Lavania and Shilpa Malik of Bioscan Research are working on CEREBO, a medical device for non-invasive brain injury screening.
• Manoj Raju, Shreyas R. Halageri and Vidvath Kamireddy of NeuralKart are building AI products for insurance and industrial safety.

Why investors are backing these sectors

1. AI was the loudest theme, but not every AI startup got easy money. Investors seemed more interested in practical AI, such as banking automation, medical imaging, tutoring, customer support, software creation and decision intelligence.
2. Clean energy also stayed hot. SolarSquare, Celloraa Energy, BatX Energies, Farm Watt Innovations and Suminter India Organics show that investors are still betting on energy transition, recycling, biomass and solar supply chains.
3. Enterprise software saw strong interest through BusinessNext, Kapture CX, Data Science Wizards, CARPL.ai and Wiffy. These companies sell to businesses, hospitals or banks, where revenue can be more predictable than consumer apps.
4. Consumer brands did not disappear either. Limelight Diamonds, Supply6, The Indus Valley, The Func. Lab, Naturis, BUILT, Aukera and LNGVTY show that investors still like brands with sharp positioning and clear customers.

Conclusion with key takeaways

The India startup funding update June 29 to July 24, 2026, shows a market that is active but careful. Big rounds went to companies with stronger business models, while early-stage funding stayed selective.

Key takeaways

• Ather Energy, Emergent, SolarSquare, BusinessNext, Raghu Vamsi Aerospace, Neo Group and Limelight Diamonds were among the biggest funding names.
• AI, enterprise SaaS, EVs, clean energy, healthtech, spacetech and consumer brands saw strong investor interest.
• Early-stage funding continued, but investors were choosy.
• The IPO pipeline also remained active, with companies like OYO parent PRISM, Fibe, Cult.fit, InMobi and others making public-market moves.

The overall message is simple. Indian startup funding is not slow. It is becoming more disciplined.

Bioscan Research has raised $1 million in seed funding, giving the medical device startup fresh capital to expand its brain injury detection technology. The round was led by Unicorn India Ventures, an early-stage investment firm that backs technology-led startups.

This is an important funding story because Bioscan is not building a regular health app or hospital software tool. It is working on a medical device called CEREBO, which is designed to help doctors and emergency teams screen for brain injuries without cutting into the body or using harmful radiation.

For a country like India, where road accidents, falls and delayed access to advanced scans remain serious problems, a faster first-level screening tool can be useful. Bioscan’s idea is simple to understand. When a patient has a head injury, every minute matters. If doctors can spot warning signs early, they can decide who needs urgent care, CT scan priority or transfer to a better-equipped hospital.

What Bioscan Research does

Bioscan Research is a medical device startup focused on early brain injury detection. Its main product is CEREBO, a portable device that uses near-infrared light and machine learning to help screen for possible bleeding inside the skull.

Near-infrared light sounds technical, but the basic idea is not too hard. The device sends safe light through parts of the head and studies how that light is absorbed. Blood absorbs light differently, so an unusual pattern can suggest a possible internal bleed.

The device then uses software to read these patterns and support clinical decision-making. It does not replace a CT scan. Instead, it works more like an early warning and triage tool.

For example, imagine a patient reaches a small hospital after a road accident. The patient may look stable, but there is still a chance of internal bleeding. If a CT scanner is not nearby, a portable screening device can help the medical team decide whether the patient needs urgent transfer or closer observation.

Founders and startup journey

Bioscan Research was founded by Anupam Lavania and Shilpa Malik in 2017.

The company is based in Ahmedabad, Gujarat, and works in the medical device space. Its work sits at the crossing point of healthcare, electronics, optics and software. That matters because building a medical device is much harder than building a consumer gadget. It needs clinical testing, safety checks, manufacturing quality and regulatory approvals.

Why this $1 million funding matters

Bioscan plans to use the funding for market expansion, regulatory approvals, product improvement and intellectual property development. In plain words, the company wants to take CEREBO to more hospitals and markets, improve the device further, and protect its technology.

This kind of funding can be useful at the seed stage because medical devices need patient capital. A startup cannot simply build a product, launch it online and scale overnight. Hospitals want proof. Regulators want documentation. Doctors want accuracy. Buyers want service support.

That is why the money is not just for sales. It is also for the slower, less glamorous work that makes a medical device reliable.

The startup has also reportedly seen strong revenue growth over the past year and is targeting further growth in the next 12 months. For investors, this suggests that the product is not only a lab idea. It is moving toward wider real-world use.

Why brain injury screening needs better tools

Traumatic brain injury, often called TBI, can happen after road accidents, falls, sports injuries, workplace accidents or physical impact. The problem is that symptoms are not always obvious in the beginning.

A person may walk into a hospital, talk normally and still have bleeding inside the skull. In other cases, mild symptoms may be ignored until the condition becomes worse.

CT scans remain the standard tool for confirming many serious head injuries. But CT scanners are expensive, not always available in smaller centres, and cannot always be used immediately in crowded emergency departments. That gap creates space for point-of-care devices.

Point-of-care simply means the test can be done close to the patient, rather than waiting for a large machine or sending samples away. If CEREBO can help doctors decide faster, it may reduce delays in treatment.

Where CEREBO can be useful

CEREBO is designed for emergency rooms, ambulances, trauma centres, defence settings and smaller healthcare facilities where quick screening is important.

In a large hospital, it may help doctors decide which patient should go for CT first. In a rural or semi-urban setting, it may help identify patients who need urgent transfer. In defence or disaster-response situations, portability can be a major advantage.

The device may also be useful in public health settings where resources are limited. India has many places where advanced imaging is not available round the clock. A portable screening device cannot solve the whole problem, but it can help bridge the first decision-making gap.

Competitors and market landscape

Bioscan Research is working in a specialized area, so its competition is not the same as a typical consumer health startup. Its closest comparison comes from other brain injury screening devices and older near-infrared based tools such as Infrascanner, which has been used in some international markets.

The bigger competition is also the existing hospital workflow. Doctors already depend on CT scans, neurological exams and clinical judgment. For Bioscan to grow, it has to prove that CEREBO fits naturally into this workflow and gives useful information without slowing teams down.

In India, other healthtech and medtech startups are also building diagnostic tools, but Bioscan’s focus on non-invasive brain injury screening gives it a fairly distinct position.

What investors may be betting on

Unicorn India Ventures appears to be backing a product that solves a real medical problem, not just a convenience problem. Brain injury detection is a serious area, and hospitals need better ways to manage emergency cases.

The investor interest may also come from the fact that medical devices built in India can serve both domestic and global markets. If a product is affordable, portable and clinically useful, it can find demand in countries where access to large hospital infrastructure is uneven.

For Bioscan, the next challenge is execution. The company has to scale sales, handle approvals, keep product quality strong and win doctor trust. In healthcare, trust grows slowly. But once a product earns it, adoption can become meaningful.

Conclusion with key takeaways

Bioscan Research’s $1 million seed funding is a strong step for a startup working on a serious healthcare problem. Its CEREBO device aims to make early brain injury screening faster, simpler and more accessible, especially in places where CT access may be limited or delayed.

The company still has a long road ahead. Medical device startups must pass through clinical, regulatory and commercial tests before becoming mainstream. But the need is clear, and the product is aimed at a problem where time can change outcomes.

Key takeaways

1. Bioscan Research raised $1 million in seed funding led by Unicorn India Ventures.
2. The startup was founded by Anupam Lavania and Shilpa Malik.
3. Its main product, CEREBO, screens for possible brain bleeding using near-infrared light and machine learning.
4. The device is meant to support early triage, not replace CT scans.
5. The funding will support expansion, regulatory approvals, product upgrades and IP creation.

Facts Input- Express Healthcare, Tech Observer, PubMed, India Science

Image Credit

Plazza raises $15 million Series A funding at a time when quick commerce is moving beyond groceries, snacks and daily household items. The next big fight is now around medicines, where speed can be more than just convenience.

For many families, buying medicines is still a tiring task. A doctor writes a prescription, one nearby pharmacy does not have the full order, another asks the customer to come later, and online platforms may take several hours or even a day. Plazza wants to fix this gap with fast delivery, wider medicine availability and a stronger pharmacy network.

The Bengaluru-based startup has raised $15 million in a Series A round co-led by Accel, Elevation Capital and Nexus Venture Partners. Existing investors All In Capital and Better Capital also joined the round. The company plans to use the money to improve its technology, strengthen AI-based inventory planning, build operations and expand into more Indian cities.

What Plazza does

Plazza is a quick medicine delivery startup. Its main promise is simple – help people get medicines and healthcare products quickly, often within 15 to 30 minutes, depending on location and availability.

The company is not trying to work like a regular e-pharmacy where users place an order and wait for delivery later. It is closer to the quick commerce model, but with a healthcare focus. That means the company has to think about nearby supply, correct inventory, pharmacy rules, prescriptions, delivery timing and customer trust all at once.

Plazza was founded in 2024 by former Zomato executive Aman Priyadarshi and Aniruddha Sen, cofounder of Kenko Health.

The startup had earlier raised $1.4 million in seed funding led by All In Capital in September 2025. That round also included Better Capital and several angel investors.

Why the funding matters

A $15 million Series A is a serious step for a young startup, especially in a category as sensitive as medicine delivery. Unlike food or grocery delivery, medicines need higher accuracy. A wrong product, delay, missing stock or poor handling can create real problems for customers.

This is why Plazza is putting money into technology and inventory systems. In simple words, the company wants to know what medicines people are likely to need, where they are needed and how to keep them available near the customer.

That is easier said than done. A normal neighbourhood pharmacy may stock a limited number of products. Plazza has been reported to offer a much wider selection, including medicines and healthcare items. Earlier reports said the startup had around 20,000 SKUs, which means individual products listed in its system.

For a customer, this matters because speed is useless if half the prescription is unavailable. Plazza’s real challenge is not only delivering fast. It has to deliver the right medicine, from a reliable source, at the right time.

The aim and purpose of Plazza

The aim of Plazza is to make medicine access faster and less stressful for urban customers.

Its purpose is not just to bring quick commerce into healthcare for the sake of trend. The bigger problem is availability. Many people still visit two or three pharmacies to complete one prescription. This is common for chronic care medicines, pediatric medicines, dermatology products, mother and baby care items and special supplements.

Imagine a parent needing fever medicine late at night. Or an elderly patient running out of a regular diabetes medicine. Or someone returning from a clinic and needing the first dose quickly. These are the moments where a fast and dependable medicine delivery service can become genuinely useful.

Plazza is trying to build a network where the app, store, inventory and delivery system work together. If done well, this can reduce the gap between prescription and access.

How Plazza’s model may work differently

Plazza appears to be building an omnichannel model. That means it is not only an app and not only a physical pharmacy. It uses physical outlets, app-based ordering and local fulfilment.

This approach is important in medicine delivery because pharmacies need licences and proper stock handling. A pure marketplace may struggle with availability, while a pure offline store may not offer app-like convenience. Plazza is trying to sit in the middle.

The company has also spoken about AI-driven inventory and assortment intelligence. In plain English, this means using software to decide which medicines should be stocked in which location. For example, one area may have higher demand for child care products, while another may need more chronic care medicines. Better planning can reduce out-of-stock cases.

This is where Plazza’s founder background also becomes relevant. Aman Priyadarshi previously worked at Zomato, where local demand, delivery operations and consumer behaviour are important parts of the business. Medicine delivery is different from food delivery, but the need for tight local operations is similar.

Competitors in quick medicine delivery

Plazza is entering a busy space. Large players already have strong brand trust, deep pockets and wider networks.

Tata 1mg, Apollo Pharmacy, PharmEasy and Netmeds are among the well-known names in online pharmacy and healthcare delivery. Quick commerce platforms are also moving into the category. Swiggy Instamart has worked with PharmEasy for medicine delivery, while Zepto and Blinkit have also explored healthcare and pharmacy-linked offerings.

There are smaller quick medicine delivery startups too. Mint earlier reported on companies such as Medino’s, Medstown and Plazza trying to build faster medicine delivery services.

Plazza’s edge will depend on whether it can keep medicine availability high and delivery times short without losing control over quality. In healthcare, trust is not optional.

The biggest challenges ahead

Plazza has a strong opportunity, but the road is not simple.

1. The first challenge is regulation. Medicines cannot be treated like chips or soft drinks. Prescription drugs need proper checks. Pharmacies need licences. Customer data must be handled carefully. Delivery partners need clear processes.
2. The second challenge is inventory cost. Keeping a wide range of medicines close to customers needs money. Some medicines may sell fast, while others may sit on shelves. Managing this balance will decide how efficient the model becomes.
3. The third challenge is customer trust. People may try a new app for snacks without thinking much. But for medicines, they want confidence. They need genuine products, correct substitutes, proper bills and clear support when something goes wrong.
4. The fourth challenge is competition from giants. Big pharmacy and quick commerce platforms can spend heavily to win customers. Plazza will need to build a sharper experience, not just offer discounts.

Why this story is important

Plazza’s funding shows that investors are still interested in quick commerce, but the market is becoming more specific. The first wave focused on groceries and daily-use items. The next wave is moving into harder categories where speed, supply and trust all matter.

Medicine delivery is one of those harder categories. If Plazza gets it right, it can solve a real pain point. If it gets it wrong, customers may quickly return to known pharmacies and larger platforms.

This is why the startup’s next phase will be important. Expanding stores is useful, but the real test will be repeat usage. Do customers come back every month for regular medicines? Do families trust Plazza during urgent needs? Can the company handle prescriptions smoothly? These answers will shape its future.

Conclusion with key takeaways

Plazza raises $15 million Series A funding to build a faster and smarter medicine delivery network. The startup is young, but it is working on a real problem that many Indian households understand.

Its aim is to make medicines more available, reduce waiting time and use technology to plan inventory better. The idea sounds simple, but execution will be tough because healthcare needs accuracy, trust and compliance.

Key takeaways

• Plazza has raised $15 million in Series A funding co-led by Accel, Elevation Capital and Nexus Venture Partners.
• The startup was founded in 2024. Reports name Aman Priyadarshi and Aniruddha Sen as founders.
• Plazza wants to deliver medicines quickly, with reported timelines of around 15 to 30 minutes in supported areas.
• The fresh funds will be used for technology, AI-based inventory planning, operations and pharmacy network expansion.
• Its competitors include Tata 1mg, Apollo Pharmacy, PharmEasy, Netmeds, Swiggy Instamart, Zepto, Blinkit and smaller quick medicine delivery startups.

Facts Input- DaijiWorld

Google has announced the 2026 class of Google for Startups Accelerator India, selecting 20 AI-first Indian startups from nearly 2,500 applications. The new cohort shows how quickly India’s startup ecosystem is moving beyond simple AI chat tools and into more serious use cases across climate, healthcare, finance, developer infrastructure, manufacturing, cybersecurity, media, legal tech, and voice AI.

This matters because AI is no longer just a feature added to a product. For many young companies, AI is now the centre of the business. It decides how the product works, how customers save time, and how companies build at scale.

The selected startups will get support through Google’s AI stack, technical mentorship, and go-to-market guidance. The programme has started with an in-person bootcamp at the Google Bengaluru campus and will run over three months.

Why this accelerator matters

For an AI startup, a good idea is only the first step. The harder part is building a product that works in real life.

A healthcare AI tool must be accurate. A finance AI agent must handle sensitive information carefully. A developer tool must save real engineering time. A climate platform must give useful and timely data. A cybersecurity product must catch risks before they become bigger problems.

That is why accelerator support can be valuable. These startups get access to technical guidance, product feedback, infrastructure support, and advice on how to sell to customers. For early-stage founders, that can reduce trial and error.

India has no shortage of AI ideas. The real test is turning those ideas into products that companies, governments, creators, hospitals, factories, and consumers can use every day.

The 20 startups in the 2026 cohort

The selected startups cover a wide range of sectors.

1. Adalat AI is working in legal tech and aims to reduce manual clerical work in courts. If used well, such tools can help speed up parts of the justice process where paperwork and case handling often take too long.
2. Aikenist is focused on healthcare, with an AI platform for radiology workflows. In simple words, it helps improve how medical imaging work moves from scan to report.
3. Aurassure works in climate tech. Its platform uses sensors and AI to provide local climate and environmental data. This can help cities, companies, and public bodies understand air quality, weather risks, and local conditions better.
4. Ayna is building for fashion brands, helping them create catalogues and product listings faster. For online sellers, getting product photos, listings, and content ready can take weeks. AI can cut that time sharply.
5. Binocs is working in finance, using agentic AI for commercial due diligence and strategic advisory. Agentic AI means systems that can take multi-step actions, not just answer one question.
6. CraftifAI is building developer infrastructure for the physical world. Its platform supports embedded software development for EdgeAI, IoT, and FPGA devices. These are the kinds of systems used in hardware, smart devices, and industrial settings.
7. Dodo Payments is building a merchant-of-record platform for AI-first and SaaS companies. This helps software companies handle payments, taxes, and compliance when selling across markets.
8. FelxifyMe works in healthcare and helps people dealing with chronic pain through AI, physiotherapy, and yoga therapy.
9. Fitsol is focused on climate and enterprise decarbonization. Its work includes carbon tracking, packaging, logistics optimization, and ESG compliance.
10. H2Loop AI is building coding models for system software engineers. This can help developers debug, understand code, and manage complex integration work.
11. Jidoka is working in manufacturing through AI-powered visual inspection and process guidance. For factories, this can help catch defects early and improve production quality.
12. CreateOS by NodeOps is building an execution layer for AI-powered software, aiming to bring the AI development lifecycle into one platform.
13. OnFinanceAI is focused on finance, especially compliance, risk, and audit workflows. This is a serious area because banks and financial companies must follow strict rules and maintain clean records.
14. Pipeshift is building an inference platform for AI in production. In simple terms, it helps companies run AI models and agents in live products.
15. PotpieAI builds a knowledge graph of code, logs, and workflows. This helps AI agents understand software systems better and support debugging or impact analysis.
16. Proxgy combines IoT, SaaS, and AI to digitize operations and build custom AI agent workflows.
17. Soundverse AI is building an AI agent platform for music creators, helping with the journey from idea to release.
18. SuperBryn works in voice AI reliability. As more companies use voice agents, testing and improving those agents becomes important.
19. TartanHQ is building an AI-native unified API platform that helps enterprises connect with more than 80 HRMS and payroll systems through one layer.
20. Zeron is focused on cybersecurity, helping teams build AI security agents that detect, rank, and fix risks across code, cloud, and vendors.

What this says about India’s AI startup market

The cohort shows a clear shift. Indian startups are not only building consumer chatbots. They are working on core business problems.

Courts need faster paperwork. Hospitals need smoother workflows. Developers need better tools. Factories need automated inspection. Financial firms need compliance support. Cities need climate data. Companies need safer AI systems.

These are not small problems. They are large, repeated, expensive problems. That is why AI can be powerful here.

For example, a factory using computer vision can spot product defects earlier. A finance company can use AI agents to reduce manual compliance work. A fashion brand can use AI cataloguing to list products faster. A voice AI company can test whether its agents are reliable before customers speak to them.

This is where the purpose of these startups becomes clear. They are trying to use AI to reduce delays, improve quality, and help people work with better information.

Competitors and market pressure

The selected startups will not have an easy road. AI is one of the most competitive markets in the world.

In developer tools, they will face global AI coding and infrastructure companies. In cybersecurity, they will compete with both Indian and international security platforms. In healthcare, they must build trust with doctors, hospitals, and patients. In climate tech, they need strong data and real deployment. In finance, they must prove security and accuracy.

Large companies such as Microsoft, Amazon, OpenAI-linked platforms, Salesforce, Adobe, Canva, and many cloud AI providers are also moving fast. Local startups have one advantage, though. They understand India’s market, languages, pricing pressure, and operational gaps better.

The winners will be the startups that solve narrow problems very well and then expand carefully.

Conclusion with key takeaways

Google’s Accelerator India 2026 cohort gives a useful picture of where Indian AI is going. The focus is moving toward real workflows, not just AI demos. These startups are working in areas where better software can save time, reduce mistakes, and support better decisions.

If the selected companies use the programme well, they can sharpen their products, improve their technology, and reach customers faster.

Key takeaways

• Google selected 20 AI-first Indian startups from nearly 2,500 applications.
• The 2026 cohort covers legal tech, healthcare, climate, finance, devtools, manufacturing, cybersecurity, media, voice AI, and enterprise software.
• The programme will run over three months and includes technical mentorship, AI stack access, and go-to-market support.
• The selected startups include Adalat AI, Aikenist, Aurassure, Ayna, Binocs, CraftifAI, Dodo Payments, FelxifyMe, Fitsol, H2Loop AI, Jidoka, CreateOS by NodeOps, OnFinanceAI, Pipeshift, PotpieAI, Proxgy, Soundverse AI, SuperBryn, TartanHQ, and Zeron.

Facts Input and Image Credit- Google

India’s startup funding scene looked active between May 30 and June 14, 2026. Investors did not only chase quick commerce or consumer apps. The bigger money flowed into climate tech, EV charging, precision healthcare, defence technology, AI assistants and community management platforms.

This is a healthy sign for the ecosystem. It shows that capital is moving toward startups solving practical problems – cleaner energy, faster EV adoption, better cancer testing, safer housing societies, wedding planning, and even autonomous systems for defence.

Key funding deals during the period

Hygenco Green Energies

It raised $105 million from IFC, Siemens Financial Services and Fullerton Carbon Action Fund. Founded by Amit Bansal, Anshul Gupta and Aashish Gupta, the Gurugram-based company works on green hydrogen and green ammonia projects.

GPS Renewables

It raised Rs. 635 crore in Series C funding. Founded in 2012 by Mainak Chakraborty and Sreekrishna Sankar, the Bengaluru company builds clean fuel and compressed biogas infrastructure.

SolarSquare Energy

It raised around $50-55 million led by B Capital, with existing investors also joining. Founded in 2015 by Shreya Mishra, Neeraj Jain and Nikhil Nahar, the company installs rooftop solar systems for homes and housing societies.

Equal AI

It raised $30 million in Series B funding co-led by Prosus Ventures and Tomales Bay Capital. Founded by Keshav Reddy, the company started as a secure data-sharing and identity infrastructure platform before moving into AI call assistant services.

Ethereal Machines

It raised $28.5 million led by Avataar Ventures, with participation from Peak XV Partners and others. The Bengaluru deeptech startup, co-founded by Kaushik Mudda and Navin Jain, works in precision manufacturing.

MyGate

It secured Rs. 225 crore from Dharana Capital. Founded in 2016 by Vijay Arisetty, Abhishek Kumar and Shreyans Daga, MyGate helps gated communities manage visitors, payments, complaints, staff and daily operations.

Exponent Energy

It raised Rs. 200 crore, co-led by 360 ONE Asset and TDK Ventures. Founded by Arun Vinayak and Sanjay Byalal, the Bengaluru startup is known for its 15-minute EV charging technology.

4baseCare

It raised an additional Rs. 38 crore in an extended Series B round led by growX Ventures and Infosys, taking its total Series B funding to Rs. 128 crore. The precision oncology startup works on cancer testing and genomics-led care.

Immuneel Therapeutics

It raised over Rs. 100 crore from Singularity AMC, Rainmatter and others. The cancer therapy startup was co-founded by Kiran Mazumdar-Shaw, Dr. Siddhartha Mukherjee and Dr. Kush M Parmar, and focuses on CAR-T cell therapy.

BazaarNow

It raised Rs. 72 crore led by Peak XV Partners, with participation from Whiteboard Capital, Antler and angel investors. The quick commerce startup was launched in 2026 by former Zepto executives Priyanshu Jain, Arjun Harish and Tarithnay Mandal.

The Wedding Company

It raised $2.75 million, about Rs. 25 crore, in seed funding led by Wellingdon Advisors LLP. Founded in 2023 by Pawan Gupta and Rahul Namdev, it offers wedding planning and fulfilment services.

Rekise Marine

It raised $9.7 million from Accel and NKSquared. The Bengaluru defence-tech startup was founded by naval architect Maitrai Maka and Rear Admiral Shekhar Mital Retd, and is building autonomous ships and underwater platforms.

Integra Robotics

It raised $1.12 million in pre-Series A funding from Finvolve, India Accelerator and GrowthCap Venture Fund. The startup works on robotics and human-in-the-loop data systems.

What this funding tells us

The biggest message is that investors are backing real-world infrastructure. Hygenco, GPS Renewables, SolarSquare and Exponent Energy all sit close to India’s energy transition. These are not light software bets. They need plants, hardware, operations, partnerships and long-term execution.

Healthcare also had a strong moment. Immuneel and 4baseCare show that Indian biotech and precision medicine startups are becoming more serious. Their work can directly affect patients, especially in cancer care, where early detection, better diagnostics and advanced therapy can change outcomes.

AI remained hot, but with a practical flavour. Equal AI is not only building a chatbot. It is trying to make an AI assistant that can screen calls, understand intent and eventually handle everyday digital tasks. That kind of AI could reduce spam and make smartphones easier to use for ordinary people.

The impact on society

Startup funding matters only when it reaches people in useful ways. In this period, many deals had clear social impact. EV charging can help delivery fleets and commercial vehicles shift from diesel to electric faster. Clean fuel startups can reduce waste and create local energy. Rooftop solar can lower household electricity bills over time. Cancer-focused startups can make advanced diagnosis and treatment more accessible.

Quick commerce and wedding-tech may look less serious, but they also solve everyday problems. BazaarNow wants to take fast delivery beyond metros. The Wedding Company is trying to organise a messy, high-stress market where families often struggle with vendor trust and unclear pricing.

Defence-tech funding is also important. Rekise Marine’s work in autonomous naval systems supports India’s push for self-reliance in strategic technology.

Founder and investor signals

Several well-known investors were active during this period. Peak XV, Prosus, B Capital, Accel, Avataar Ventures, Dharana Capital, TDK Ventures, 360 ONE Asset, India Accelerator, Wellingdon Advisors and IFC appeared across deals.

Founder quality also stood out. Many teams are led by domain-heavy founders – energy specialists, healthcare researchers, naval experts, manufacturing engineers and experienced startup operators. That is a shift from pure app-building to deeper industry knowledge.

Conclusion with key takeaways

India’s startup funding between May 30 and June 14, 2026 showed a balanced market. Investors backed climate tech, EVs, AI, healthcare, defence, quick commerce and community platforms.

Key takeaways

Climate and clean energy saw strong investor interest through Hygenco, GPS Renewables, SolarSquare and Exponent Energy. Healthcare funding remained meaningful, led by Immuneel Therapeutics and 4baseCare.

AI funding moved toward practical use cases, especially with Equal AI. Consumer and lifestyle startups like BazaarNow and The Wedding Company continued to attract early-stage capital.

The ecosystem looks more mature, with investors favouring startups that solve real operational, social or infrastructure problems.